1
Stephen G Hoge, Antonin de Fougerolles, Jeff Lynn Ellsworth: Compositions and methods of altering cholesterol levels. Moderna Therapeutics, DT Ward PC, Donna T Ward, Jennifer F Bryan, March 17, 2015: US08980864 (9 worldwide citation)

The present invention relates to compositions, methods and kits using polynucleotides, primary transcripts and mmRNA molecules.


2
COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS. MODERNA THERAPEUTICS, September 18, 2014: US20140275227-A1

The present invention relates to compositions, methods and kits using polynucleotides, primary transcripts and mmRNA molecules.


3
COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS. January 1, 2015: US20150005372-A1

The present invention relates to compositions, methods and kits using polynucleotides, primary transcripts and mmRNA molecules.


4
Compositions and Methods of Altering Cholesterol Levels. Moderna Therapeutics, May 19, 2016: US20160136236-A1

The present invention relates to compositions, methods and kits using polynucleotides, primary transcripts and mmRNA molecules. The present invention also relates to compositions and methods for altering cholesterol levels using polynucleotides, primary transcripts and mmRNA molecules.


5
COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS. Moderna TX, February 8, 2018: US20180036369-A1

The present invention relates to compositions, methods and kits using polynucleotides, primary transcripts and mmRNA molecules.